Leukemia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Leukemia stocks.

Leukemia Stocks Recent News

Date Stock Title
May 15 INO Inovio Pharmaceuticals, Inc. (INO) Presents at 2024 RBC Capital Markets Global Healthcare Conference (Transcript)
May 15 TEVA Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
May 15 SYRS Syros Pharmaceuticals Inc (SYRS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
May 15 SYRS Q1 2024 Syros Pharmaceuticals Inc Earnings Call
May 14 INO Inovio Pharmaceuticals, Inc. (INO) The Citizens JMP Life Sciences Conference (Transcript)
May 14 TEVA Teva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference (Transcript)
May 14 SYRS Syros Pharmaceuticals, Inc. (SYRS) Q1 2024 Earnings Call Transcript
May 14 TEVA Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
May 14 SYRS Syros Pharmaceuticals GAAP EPS of -$0.10 beats by $0.77
May 14 KURA Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
May 14 SYRS Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update
May 14 TEVA Israel’s Once-Dominant Drugmaker Is Revived by Innovation
May 14 INO Inovio Pharmaceuticals Inc (INO) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
May 14 INO Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript
May 13 INO Inovio Pharmaceuticals, Inc. (INO) Q1 2024 Earnings Call Transcript
May 13 INO Inovio Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 13 INO Inovio Pharmaceuticals GAAP EPS of -$1.31 misses by $0.31
May 13 CRDF Cardiff Oncology to Present at Upcoming Investor Conferences in May
May 13 INO INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 13 SYRS Syros Pharmaceuticals Q1 2024 Earnings Preview
Leukemia

Leukemia, also spelled leukaemia, is a group of cancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. These white blood cells are not fully developed and are called blasts or leukemia cells. Symptoms may include bleeding and bruising problems, feeling tired, fever, and an increased risk of infections. These symptoms occur due to a lack of normal blood cells. Diagnosis is typically made by blood tests or bone marrow biopsy.The exact cause of leukemia is unknown. A combination of genetic factors and environmental (non-inherited) factors are believed to play a role. Risk factors include smoking, ionizing radiation, some chemicals (such as benzene), prior chemotherapy, and Down syndrome. People with a family history of leukemia are also at higher risk. There are four main types of leukemia—acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML)—as well as a number of less common types. Leukemias and lymphomas both belong to a broader group of tumors that affect the blood, bone marrow, and lymphoid system, known as tumors of the hematopoietic and lymphoid tissues.Treatment may involve some combination of chemotherapy, radiation therapy, targeted therapy, and bone marrow transplant, in addition to supportive care and palliative care as needed. Certain types of leukemia may be managed with watchful waiting. The success of treatment depends on the type of leukemia and the age of the person. Outcomes have improved in the developed world. The average five-year survival rate is 57% in the United States. In children under 15, the five-year survival rate is greater than 60 to 85%, depending on the type of leukemia. In children with acute leukemia who are cancer-free after five years, the cancer is unlikely to return.In 2015, leukemia was present in 2.3 million people and caused 353,500 deaths. In 2012 it newly developed in 352,000 people. It is the most common type of cancer in children, with three quarters of leukemia cases in children being the acute lymphoblastic type. However, about 90% of all leukemias are diagnosed in adults, with AML and CLL being most common in adults. It occurs more commonly in the developed world.

Browse All Tags